The IMF and International Myeloma Working Group Agree: No Evidence Long Term Use Of Revlimid Causes Secondary Cancer In Patients Who Have Not Undergone Stem Cell Transplantation

Friday I wrote an article about the International Myeloma Foundation's (IMF) response to the new Revlimid/secondary cancer controversy:  The International Myeloma Foundation's Official Statement Concerning Data Linking Long Term/Post Transplant R...